Singapore, 24 May 2023 – UBS launched its 9th flagship Healthtech Summit in Singapore with over 250 healthcare practitioners, corporates, innovators, and investors. This year, the conference provided insights into the leading and disruptive innovations in healthcare and how digital technology will transform the healthcare landscape. Across Asia, ongoing digitalization of the healthcare system would redefine investment opportunities for corporates, investors and most importantly, the lives of patients.
Edmund Koh, President APAC, UBS said: “It is encouraging to see over 250 healthcare leaders, investors and innovators at our flagship Healthtech Summit in Singapore. UBS has had a strong track record in Asia’s healthcare sector for the past two decades. To date, we have done 15 of the 20 largest Asian healthcare IPOs. Within Asia, we expect increased demand for healthcare services. We believe that private markets allow investors to capture an illiquidity premium and are important sources of funding for early-stage drug and medical device development. This is why our flagship Healthtech Summit brings the best minds in healthcare and private investors to explore opportunities in medtech and biopharma innovation together.”
Patricia Quek, Head of UBS Global Wealth Management Singapore said: ”We view healthcare as a sector offering structural growth over the longer term, supported by demographic needs. This topic is close to the hearts of investors and there are many new symbiotic relationships converging amongst online and offline healthcare businesses that create exciting new opportunities. Our focus is on mega trends over the next five years in preventive healthcare and longevity. Many of us will live beyond 100 sooner than later. Looking ahead, predictive Artificial Intelligence has accelerated drug discoveries, with the potential to benefit patients and consumers.”
The conference presented a robust selection of panel discussions with a mix of global and regional leaders in the healthcare industry, innovators and emerging market disruptors. The key plenaries include a presentation on how the latest revolutionary technologies such as Artificial Intelligence would redefine the future of healthcare and the future of precision medicine fueled by a rapidly growing bio pharma industry. The participants discussed a wide range of topics including how technology could improve patient outcomes, reduce cost, bridge online-to-offline patient experience and optimize the healthcare industry.
Some of the panel moderators and speakers at the UBS Healthtech Summit 2023 included:
- Daniel Kraft, Stanford & Harvard trained MD, Physician-Scientist & Inventor; Founder, NextMed Health & Digital Health; Chair, XPRIZE Pandemic & Health Alliance; Founder, Exponential Medicine
- Jim Mellon, Co-founder & Deputy Chairman, Juvenescence
- Zhou Lihan, PHD, Co-founder & CEO, MiRXES Group
- Edward Booty, Chief Executive Officer, reach52
UBS in Singapore
Singapore is one of our top two major international booking centers for UBS's wealth management business in the region, the headquarters for UBS's investment banking business in South Asia, and APAC hub for fx, rates and credit. UBS in Singapore also houses the UBS University (APAC’s regional headquarters for learning and development), the Cyber Fusion Centre (first of its kind in UBS globally) and the headquarters for Tech Connect Southeast Asia.
UBS convenes the global ecosystem for investing, where people and ideas are connected and opportunities brought to life, and provides financial advice and solutions to wealthy, institutional and corporate clients worldwide, as well as to private clients in Switzerland. UBS offers investment solutions, products and impactful thought leadership, is the leading global wealth manager, provides large-scale and diversified asset management, focused investment banking capabilities, and personal and corporate banking services in Switzerland. The firm focuses on businesses that have a strong competitive position in their target markets, are capital efficient and have an attractive long-term structural growth or profitability outlook.
UBS is present in all major financial centers worldwide. It has offices in more than 50 regions and locations, with about 30% of its employees working in the Americas, 30% in Switzerland, 19% in the rest of Europe, the Middle East and Africa and 21% in Asia Pacific. UBS Group AG employs more than 72,000 people around the world. Its shares are listed on the SIX Swiss Exchange and the New York Stock Exchange (NYSE).